TuHURA Biosciences (HURA) Change in Receivables (2010 - 2012)
TuHURA Biosciences' (HURA) quarterly Change in Receivables came in at $5000.0 in Q1 2012, little changed quarter-over-quarter from $5000.0 in Q4 2011.
TuHURA Biosciences (HURA) Change in Receivables (2010 - 2012) Analysis & Trends
TuHURA Biosciences' Change in Receivables history runs 3 years deep, the most recent figure standing at $5000.0 for Q1 2012.
- On a quarterly basis, Change in Receivables changed N/A year-over-year to $5000.0 in Q1 2012; TTM through Dec 2012 was $5000.0, a N/A change from a year earlier, with the FY2012 full-year figure at $5000.0, up 200.0% from the prior year.
- Change in Receivables was little changed at $5000.0 in Q1 2012 per HURA's latest filing, from $5000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $5000.0 in Q3 2011 and bottomed at -$5000.0 in Q4 2010.
- The 3-year median for Change in Receivables is $5000.0 (2011), against an average of $1000.0.
- Biggest YoY gain for Change in Receivables was 200.0% in 2011; the steepest drop was 200.0% in 2011.
- Year by year, Change in Receivables stood at -$5000.0 in 2010, then soared by 200.0% to $5000.0 in 2011, then changed by 0.0% to $5000.0 in 2012.
- Per Business Quant, the three latest HURA Change in Receivables figures stand at $5000.0 (Q1 2012), $5000.0 (Q4 2011), and $5000.0 (Q3 2011).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 5,000.00 |
| Mar 31, 2012 | 5,000.00 |
| Dec 31, 2011 | 5,000.00 |
| Dec 31, 2011 | 5,000.00 |
| Sep 30, 2011 | 5,000.00 |
| Sep 30, 2011 | 5,000.00 |
| Jun 30, 2011 | -5,000.00 |
| Jun 30, 2011 | -5,000.00 |
| Dec 31, 2010 | -5,000.00 |
| Dec 31, 2010 | -5,000.00 |